title: Low rejection rate with high-dose ATG bolus therapy in simultaneous pancreas and kidney transplantation.
authors.affiliation: Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
authors.forename: F
authors.initials: F
authors.lastname: Saudek
authors.forename: M
authors.initials: M
authors.lastname: Adamec
authors.forename: R
authors.initials: R
authors.lastname: Koznarová
authors.forename: T
authors.initials: T
authors.lastname: Jedináková
authors.forename: P
authors.initials: P
authors.lastname: Boucek
authors.forename: L
authors.initials: L
authors.lastname: Voska
mesh_terms: D000328:Adult; D000961:Antilymphocyte Serum / Q000008:administration & dosage / Q000627:therapeutic use*; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery*; D003928:Diabetic Nephropathies / Q000601:surgery*; D018572:Disease-Free Survival; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control*; D006085:Graft Survival; D006801:Humans; D007275:Injections, Intravenous; D007676:Kidney Failure, Chronic / Q000601:surgery*; D016030:Kidney Transplantation / Q000276:immunology* / Q000379:methods / Q000401:mortality; D018655:Lymphocyte Count; D008297:Male; D016035:Pancreas Transplantation / Q000276:immunology* / Q000379:methods / Q000401:mortality; D010976:Platelet Count; D012189:Retrospective Studies; D015996:Survival Rate; D013997:Time Factors
chemical_list: D000961:Antilymphocyte Serum